Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| plasmacytoid dendritic cell | 10 studies | 27% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 21% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 4255.39 | 245 / 245 | 100% | 12.11 | 502 / 502 |
| brain | 100% | 2838.15 | 2637 / 2642 | 100% | 16.95 | 703 / 705 |
| thymus | 100% | 4274.92 | 653 / 653 | 100% | 11.82 | 602 / 605 |
| adrenal gland | 100% | 3417.23 | 258 / 258 | 98% | 12.50 | 225 / 230 |
| breast | 100% | 2247.32 | 459 / 459 | 98% | 9.38 | 1093 / 1118 |
| pancreas | 99% | 1124.28 | 324 / 328 | 98% | 6.63 | 175 / 178 |
| kidney | 100% | 2221.91 | 89 / 89 | 94% | 7.45 | 850 / 901 |
| ovary | 100% | 5556.13 | 180 / 180 | 94% | 5.75 | 404 / 430 |
| intestine | 100% | 2645.32 | 965 / 966 | 92% | 5.61 | 484 / 527 |
| bladder | 100% | 3346.33 | 21 / 21 | 87% | 4.47 | 437 / 504 |
| stomach | 100% | 2451.85 | 359 / 359 | 85% | 4.83 | 242 / 286 |
| lung | 99% | 1735.42 | 575 / 578 | 85% | 4.43 | 979 / 1155 |
| skin | 99% | 1328.26 | 1787 / 1809 | 85% | 4.02 | 399 / 472 |
| uterus | 100% | 4405.33 | 170 / 170 | 70% | 4.04 | 320 / 459 |
| esophagus | 93% | 2714.57 | 1348 / 1445 | 67% | 2.73 | 122 / 183 |
| liver | 58% | 413.15 | 131 / 226 | 60% | 2.06 | 242 / 406 |
| blood vessel | 100% | 3426.16 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.62 | 1 / 1 |
| spleen | 99% | 1336.87 | 239 / 241 | 0% | 0 | 0 / 0 |
| adipose | 99% | 1702.75 | 1194 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 98% | 5.82 | 78 / 80 |
| heart | 97% | 1607.56 | 832 / 861 | 0% | 0 | 0 / 0 |
| muscle | 96% | 1188.83 | 770 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 47% | 2.00 | 21 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 45% | 1.24 | 13 / 29 |
| peripheral blood | 26% | 334.26 | 243 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007346 | Biological process | regulation of mitotic cell cycle |
| GO_0007160 | Biological process | cell-matrix adhesion |
| GO_0009986 | Cellular component | cell surface |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0005634 | Cellular component | nucleus |
| GO_0005515 | Molecular function | protein binding |
| Gene name | TMEM8B |
| Protein name | Transmembrane protein 8B (Nasopharyngeal carcinoma-associated gene 6 protein) (Protein NAG-5) (Protein NGX6) Transmembrane protein 8B |
| Synonyms | NGX6 C9orf127 |
| Description | FUNCTION: May function as a regulator of the EGFR pathway. Probable tumor suppressor which may function in cell growth, proliferation and adhesion. . |
| Accessions | ENST00000377996.5 [A6NDV4-2] A0A2R8Y2M5 ENST00000377988.6 [A6NDV4-1] A6NDV4 ENST00000377991.9 [A6NDV4-1] ENST00000439587.6 [A6NDV4-2] ENST00000650015.1 [A6NDV4-1] ENST00000643932.2 |